dc.contributorUniversidade Estadual Paulista (Unesp)
dc.contributorUniversidade de São Paulo (USP)
dc.date.accessioned2014-05-20T14:20:15Z
dc.date.accessioned2022-10-05T15:20:05Z
dc.date.available2014-05-20T14:20:15Z
dc.date.available2022-10-05T15:20:05Z
dc.date.created2014-05-20T14:20:15Z
dc.date.issued2009-12-01
dc.identifierMedicinal Chemistry Research. Cambridge: Birkhauser Boston Inc, v. 18, n. 9, p. 703-711, 2009.
dc.identifier1054-2523
dc.identifierhttp://hdl.handle.net/11449/26082
dc.identifier10.1007/s00044-008-9161-9
dc.identifierWOS:000272617700001
dc.identifier4484083685251673
dc.identifier1308042794786872
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/3899117
dc.description.abstractWe describe herein an evaluation of the trypanocidal effect of eight piperamides (1-8) isolated from Piper tuberculatum bearing dihydropyridone, piperidine, and isobutyl moieties against epimastigote forms of Trypanosoma cruzi, the causative agent of Chagas' disease. Based on such results, three hydrogenated and two hydrolyzed derivatives (10-14) were prepared and evaluated as well. The dihydropyridone amides (1-3) displayed higher anti-trypanosomal activity. The (Z)-piplartine (1) showed higher activity with a 50% inhibition concentration (IC(50)) value of 10.5 mu M, almost four times more potent than the positive control, benznidazole (IC(50) = 42.7 mu M), and should be further evaluated as a suitable hit for the design of new antiprotozoal agents.
dc.languageeng
dc.publisherBirkhauser Boston
dc.relationMedicinal Chemistry Research
dc.relation1.607
dc.relation0,422
dc.rightsAcesso restrito
dc.sourceWeb of Science
dc.subjectPiperamides
dc.subjectAnti-trypanosomal
dc.subjectTrypanosoma cruzi
dc.subjectPiper tuberculatum
dc.subjectPiperaceae
dc.titlePiperamides and their derivatives as potential anti-trypanosomal agents
dc.typeArtigo


Este ítem pertenece a la siguiente institución